Quarterly report pursuant to Section 13 or 15(d)

Note 12 - Intangible Assets, Net (Tables)

v3.24.1.1.u2
Note 12 - Intangible Assets, Net (Tables)
3 Months Ended
Mar. 31, 2024
Notes Tables  
Schedule of Finite-Lived Intangible Assets [Table Text Block]
   

March 31, 2024

 
   

(Unaudited)

 
   

Gross amount

   

Accumulated amortization

   

Net Amount

 

Pharmacy records

  $ 8,130     $ (1,219 )   $ 6,911  

Trade names

    4,700       (353 )     4,347  

Developed technology

    2,880       (432 )     2,448  

Customer Contracts

    250       (231 )     19  

Total intangible assets

  $ 15,960     $ (2,235 )   $ 13,725  
   

December 31, 2023

 
   

(Audited)

 
   

Gross amount

   

Accumulated amortization

   

Net Amount

 

Pharmacy records

  $ 8,130     $ (807 )   $ 7,323  

Trade names

    4,700       (224 )     4,476  

Developed technology

    2,880       (281 )     2,599  

Customer Contracts

    250       (225 )     25  

Total intangible assets

  $ 15,960     $ (1,537 )   $ 14,423  
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

Year

    Amount  

2024 (remaining nine months)

  $ 2,023  

2025

    2,672  

2026

    2,672  

2027

    2,672  

2028

    1,571  

Thereafter

    2,115  

Total

  $ 13,725